This, and given the fact that the targeting of NF-κB by several active compounds is elucidated to ameliorate diverse pathophysiological conditions, more pre-clinical research might also bestow upon platelet NF-κB a therapeutic potential in cardiovascular diseases. Here, NFKB1 is linked to cardiovascular disorder.